Arbutus Biopharma's earnings of $0.02 surpassed expectations, while profits fell short of forecasts.
Daily NewsAccording to Arbutus Biopharma's (NASDAQ: ABUS) report, the earnings per share for the first quarter was -$0.070, which is $0.02 better than analysts' expectation...
Read More